The dermatology market’s allure lies in its promising market dynamics, including opportunities for consolidating practices, leveraging economies of scale, and optimizing operational efficiencies. Additionally, the growing consumer awareness and emphasis on skin health have contributed to a robust and expanding market demand. With relatively favorable reimbursement structures, evolving regulations, and technological advancements supporting the sector, PE firms are keen to invest in dermatology practices and capitalize on their growth potential, VMG Health reports. Read more.
Related Posts
Digital Health VCs Eye Healthcare Workforce, Cancer Care as Ripe for Startups in 2023
VCs plan to make roughly the same number of health tech investments this year as compared to 2021, according to a new survey of 50 digital health venture capital investors conducted by GSR Ventures.
December 2, 2022
RH Capital Raises $40M+ to Tackle Reproductive and Maternal Health Equity
The fund’s lead investors include Tara Health Foundation, Skoll Foundation, The Impact Seat Foundation, Houssian Foundation, Argosy Foundation and The Case for Her.
November 3, 2022
CMS Considers Hospital Price, Data Transparency Changes in 2024
CMS proposed changing the hospital price transparency regulations to make them more accessible to patients and more strictly enforce compliance for 2024.
July 14, 2023
Medicaid Coverage for Substance Abuse Treatment has Improved
Coverage for SUD treatment and opioid use disorder (OUD) medications increased substantially over the study period, which ran from 2014 to 2021.
August 16, 2023